Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Tavitian

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Bulletin De L'Academie Nationale De Medecine|February 3, 2010
[Molecular approaches in experimental neuroimaging]Bertrand Tavitian
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2009
Darwinian molecular imagingBertrand Tavitian, Uwe Haberkorn
Medecine Sciences : M/S|February 27, 2024
[Takotsubo syndrome: Cardiac metabolism at the heart of the problem ?]Thulaciga Yoganathan, Bertrand Tavitian
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 3, 2012
Noninvasive molecular imaging of neuroinflammationAndreas H Jacobs, Bertrand Tavitian,
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 7, 2020
Molecular imaging of free radicals for anthracycline-induced cardiotoxicity: See the burn?Fabien Hyafil, Mariana Mirabel, Bertrand Tavitian
Molecular Imaging|March 16, 2012
In vivo evidence that the increase in matrix metalloproteinase activity occurs early after cerebral ischemiaAbraham Martín, Anikitos Garofalakis, Bertrand Tavitian
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2019
A future for PET imaging in Alzheimer's diseaseAurélie Kas, Raffaella Migliaccio, Bertrand Tavitian
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2011
Realizing the full potential of PET for measuring the biodistribution of novel anticancer agentsTerry Jones, Pat Price, Bertrand Tavitian
Current Pharmaceutical Design|June 8, 2002
Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectivesCheraz Khélifi Younes, Raphaël Boisgard, Bertrand Tavitian
Clinical & Experimental Metastasis|November 12, 2009
Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolutionLaila Illán Rubio, Bertrand Tavitian, Elina Zueva
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Bulletin De L'Academie Nationale De Medecine|February 3, 2010
[Molecular approaches in experimental neuroimaging]Bertrand Tavitian
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2009
Darwinian molecular imagingBertrand Tavitian, Uwe Haberkorn
Medecine Sciences : M/S|February 27, 2024
[Takotsubo syndrome: Cardiac metabolism at the heart of the problem ?]Thulaciga Yoganathan, Bertrand Tavitian
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 3, 2012
Noninvasive molecular imaging of neuroinflammationAndreas H Jacobs, Bertrand Tavitian,
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 7, 2020
Molecular imaging of free radicals for anthracycline-induced cardiotoxicity: See the burn?Fabien Hyafil, Mariana Mirabel, Bertrand Tavitian
Molecular Imaging|March 16, 2012
In vivo evidence that the increase in matrix metalloproteinase activity occurs early after cerebral ischemiaAbraham Martín, Anikitos Garofalakis, Bertrand Tavitian
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2019
A future for PET imaging in Alzheimer's diseaseAurélie Kas, Raffaella Migliaccio, Bertrand Tavitian
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2011
Realizing the full potential of PET for measuring the biodistribution of novel anticancer agentsTerry Jones, Pat Price, Bertrand Tavitian
Current Pharmaceutical Design|June 8, 2002
Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectivesCheraz Khélifi Younes, Raphaël Boisgard, Bertrand Tavitian
Clinical & Experimental Metastasis|November 12, 2009
Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolutionLaila Illán Rubio, Bertrand Tavitian, Elina Zueva
Pageof 12